Trump's FDA Pick Outlined Vision for 'Conservative-Based' Science
Heidi Overton proposed new academic journals for research supporting right-wing health policies.
1Conservative Science Vision
In a 2023 podcast interview, Heidi Overton called for creating alternative publishing systems for research that explicitly supports conservative policies. Nominated to lead the U.S. Food and Drug Administration (FDA), Overton outlined a 20-year vision to align research funding and infrastructure with conservative values. Her proposal includes establishing new funding mechanisms and publication outlets for right-aligned scientific work.
2New Approach to Academic Publishing
Overton criticized current academic publishing as biased against conservative views, advocating for new journals. She referenced left-leaning publications like 'Journal of Adolescent Transgender Medicine' (though no such journal exists) and claimed NIH and CDC research priorities are politically skewed. Overton argued for dedicated funding streams supporting studies from conservative perspectives, questioning mainstream scientific consensus.
3Political Career and Connections
A White House aide and former chief policy officer at America First Policy Institute, Overton is a key supporter of Robert F. Kennedy Jr.'s 'Make America Healthy Again' campaign. The physician served on Trump's COVID-19 response team during his first term and was present when he signed an executive order altering childhood vaccine schedules in 2026, advocating to split MMR into separate shots.
4Vaccine Policy Stance
Overton's push to separate the MMR vaccine into three individual injections has sparked controversy, as the combined vaccine's safety and efficacy are well-established. Following her FDA nomination, nonprofit Stand Up for Science circulated clips of her 2023 comments. The organization, formed in response to Trump-era cuts to science agencies, highlights concerns about political interference in research.
5Calls for Science Agency Reforms
Overton's nomination reignited debates about budget cuts and political influence in federal science institutions. As health policy director at America First Policy Institute, she championed a 'Healthy America' vision. Her proposals represent part of conservative efforts to create alternative knowledge production channels outside traditional academic publishing.
6Scientific Neutrality Debates
Stand Up for Science CEO Colette Delawalla characterized Overton's remarks as 'dividing science along partisan lines.' The organization, founded in response to Trump administration cuts to science agencies, advocates protecting independent scientific inquiry. Delawalla challenged Overton's assertion that 'knowledge isn't inherently neutral,' warning against politicizing research.
7FDA's Future Direction
If confirmed, Overton could bring significant changes to FDA's drug approval processes and public health policies. Experts anticipate conservative values playing greater roles in vaccine policies and clinical trial oversight. While alarming some in the scientific and pharmaceutical communities, this prospect has been welcomed by certain conservative groups seeking policy alignment.
8Intersection of Science and Politics
The Overton nomination highlights tensions between political oversight of scientific institutions and academic freedom. Critics warn that leadership appointments at agencies like FDA increasingly prioritize political loyalty over scientific merit. Analysts caution that such trends could undermine public health policies and erode trust in scientific credibility long-term.